GENETIC RISK FACTORS OF ANTHRACYCLINE CARDIOTOXICITY - RELEVANT POLYMORPHISMS IDENTIFIED IN ENZYMES AND TRANSPORTERS OF ANTHRACYCLINE PHARMACOKINETICS

被引：0
|
作者：
Kutszegi, Nora Zsofia [1 ]
Semsei, Agnes F. [1 ]
Lautner-Csorba, Orsolya [1 ]
Hegyi, Marta [2 ]
Szabolcs, Judit [2 ]
Benyo, Gabor [3 ]
Szalai, Csaba [1 ,4 ]
Kovacs, Gabor T. [2 ]
Erdelyi, Daniel Janos [2 ]
机构：
[1] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Dept Paediat 2, H-1085 Budapest, Hungary
[3] Szent Laszlo Hosp, Budapest, Hungary
[4] Csertex Res Lab, Budapest, Hungary
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1101 / 1101
页数：1
相关论文
共 50 条
  • [1] Risk factors for anthracycline-associated cardiotoxicity
    Raquel E. Reinbolt
    Roshan Patel
    Xueliang Pan
    Cynthia Dawn Timmers
    Robert Pilarski
    Charles L. Shapiro
    Maryam B. Lustberg
    Supportive Care in Cancer, 2016, 24 : 2173 - 2180
  • [2] Risk factors for anthracycline-associated cardiotoxicity
    Reinbolt, Raquel E.
    Patel, Roshan
    Pan, Xueliang
    Timmers, Cynthia Dawn
    Pilarski, Robert
    Shapiro, Charles L.
    Lustberg, Maryam B.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (05) : 2173 - 2180
  • [3] Risk Factors for Anthracycline-Induced Cardiotoxicity
    Qiu, Shuo
    Zhou, Tian
    Qiu, Bo
    Zhang, Yuxin
    Zhou, Yonggang
    Yu, Huihui
    Zhang, Jingyi
    Liu, Li
    Yuan, Lijun
    Yang, Guodong
    Duan, Yunyou
    Xing, Changyang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [4] Drug transporters and anthracycline-induced cardiotoxicity
    Huang, Kevin M.
    Hu, Shuiying
    Sparreboom, Alex
    PHARMACOGENOMICS, 2018, 19 (11) : 883 - 888
  • [5] Additional Genetic Risk Factors for Anthracycline-Induced Cardiotoxicity in Pediatric Cancer
    Scott, E.
    Drogemoller, B.
    Wright, G.
    Carleton, B.
    Ross, C.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S127 - S128
  • [6] Risk factors for anthracycline-associated cardiotoxicity.
    Reinbolt, Raquel E.
    Patel, Roshan
    Pan, Xueliang Jeff
    Timmers, Cynthia Dawn
    Pilarski, Robert
    Shapiro, Charles L.
    Lustberg, Maryam B.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Clinical risk prediction in anthracycline cardiotoxicity
    Ky, Bonnie
    Warneke, Carla L.
    Lenihan, Daniel John
    Cheema, Puneet S.
    Moore, Dennis Frederic
    Campbell, Mark G.
    Yeshwant, Chilakamarri
    Adams, Paul T.
    Krone, Ron
    Carver, Joseph R.
    Nasta, Sunita
    Svoboda, Jakub
    Schuster, Stephen J.
    Reddy, Nishitha M.
    Patel, Sunil M.
    Rieber, Alyssa G.
    Johnson, Marcella M.
    Fisch, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Anthracycline-induced cardiotoxicity: molecular and genetic predictors for risk assessment
    Grakova, E.
    Shilov, S. N.
    Berezikova, E. N.
    Popova, A. A.
    Neupokoeva, M. N.
    Kopeva, K., V
    Van-Tin-Gao, A. A.
    Ratushniak, E. T.
    Teplyakov, A. T.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1146 - 1146
  • [9] Genetic determinants of anthracycline cardiotoxicity - ready for the clinic?
    Craig, Lauren A.
    Ekert, Paul G.
    Conyers, Rachel
    Elliott, David A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 1141 - 1142
  • [10] Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy
    Cui, Lulu
    Huang, Jia
    Zhan, Yongtao
    Qiu, Ni
    Jin, Huan
    Li, Jia
    Huang, Huiqi
    Li, Hongsheng
    LIFE SCIENCES, 2021, 276
12345